APA (7th ed.) Citation

Qi, X., Yu, X., Wei, L., Jiang, H., Dong, J., Li, H., . . . Li, T. (2024). Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor (AMPAR) potentiator LT‐102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia. CNS Neuroscience & Therapeutics, 30(4), 1. https://doi.org/10.1111/cns.14713

Chicago Style (17th ed.) Citation

Qi, Xueyu, et al. "Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic Acid Receptor (AMPAR) Potentiator LT‐102: A Promising Therapeutic Agent for Treating Cognitive Impairment Associated with Schizophrenia." CNS Neuroscience & Therapeutics 30, no. 4 (2024): 1. https://doi.org/10.1111/cns.14713.

MLA (9th ed.) Citation

Qi, Xueyu, et al. "Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic Acid Receptor (AMPAR) Potentiator LT‐102: A Promising Therapeutic Agent for Treating Cognitive Impairment Associated with Schizophrenia." CNS Neuroscience & Therapeutics, vol. 30, no. 4, 2024, p. 1, https://doi.org/10.1111/cns.14713.